10 March 2020

CANADA – MDA Pharmaceuticals Rebrands as Juno

Effective March 2020, MDA Pharmaceuticals shall officially be known as Juno Pharmaceuticals Canada (“JPC”). This rebranding serves to better align the company’s brand with that of its international parent, particularly as the company begins to rapidly expand its local market presence.

No changes to MDA/JPC personnel are anticipated in conjunction with the aforementioned rebranding.